Clinical use of thyroglobulin: not only thyroid cancer

被引:7
作者
Agata, Berlinska [1 ]
Renata, Swiatkowska-Stodulska [1 ]
机构
[1] Med Univ Gdansk, Fac Med, Dept Endocrinol & Internal Med, Gdansk, Poland
关键词
Thyroglobulin; Thyroid; Thyroiditis; Immune-checkpoint inhibitors; COVID-19; BLOOD-SPOT THYROGLOBULIN; IODINE NUTRITION STATUS; TOXIC NODULAR GOITER; SERUM THYROGLOBULIN; STRUMA OVARII; GRAVES-DISEASE; DIAGNOSIS; SUBACUTE; HYPOTHYROIDISM; INDICATOR;
D O I
10.1007/s12020-023-03658-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroglobulin (TG) is a dimeric glycoprotein produced exclusively by mature thyroid tissue and stored within the follicular lumen. It is essential for the organification of iodine and the production of thyroid hormones. The concentration of TG in the bloodstream varies between individuals and depends on factors such as thyroid mass, stimulation of the gland by thyrotropin or autoantibodies, and tissue destruction. TG is essential to monitor patients with differentiated thyroid cancer; however, its use is not limited only to this clinical entity. Measurement of circulating TG can provide better insight into numerous clinical scenarios, such as destructive thyroiditis, presence of ectopic thyroid tissue, thyroid trauma, factitious thyrotoxicosis, or iodine nutrition. Lately, TG has found its new clinical use in immune checkpoint-related thyroid dysfunction. TG measurement should be performed carefully in patients with antithyroglobulin antibodies due to possible laboratory interferences. In this review, we offer a summary of current knowledge about the clinical use of TG and the implications it brings to daily practice.
引用
收藏
页码:786 / 799
页数:14
相关论文
共 123 条
[1]   SERUM THYROGLOBULIN CONCENTRATION AS AN INDICATOR FOR ASSESSING THYROID-STIMULATION IN PATIENTS WITH GRAVES-DISEASE DURING ANTITHYROID DRUG-THERAPY [J].
AIZAWA, T ;
ISHIHARA, M ;
KOIZUMI, Y ;
HASHIZUME, K ;
TAKASU, N ;
YAMADA, T ;
KOBAYASHI, I ;
WATANABE, T ;
SHIMIZU, Z .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (02) :175-180
[2]   Hypothyroidism in Cancer Patients on Immune Checkpoint Inhibitors with anti-PD1 Agents: Insights on Underlying Mechanisms [J].
Alhusseini, M. ;
Samantray, J. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (04) :267-269
[3]   Low serum TSH in the acute phase of COVID-19 pneumonia: thyrotoxicosis or a face of "non-thyroidal illness syndrome"? [J].
Assimakopoulos, Stelios F. ;
Markantes, Georgios K. ;
Papageorgiou, Dimitris ;
Mamali, Irene ;
Markou, Kostas B. ;
Marangos, Markos ;
Michalaki, Marina A. .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (11) :E420-E423
[4]   Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients [J].
Baek, Han-Sang ;
Jeong, Chaiho ;
Shin, Kabsoo ;
Lee, Jaejun ;
Suh, Heysun ;
Lim, Dong-Jun ;
Kang, Moo Il ;
Ha, Jeonghoon .
BMC ENDOCRINE DISORDERS, 2022, 22 (01)
[5]   Thyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods [J].
Barbesino, Giuseppe ;
Algeciras-Schimnich, Alicia ;
Bornhorst, Joshua .
JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 7 (01)
[6]   Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients [J].
Basak, Edwin A. ;
van der Meer, Jan W. M. ;
Hurkmans, Daan P. ;
Schreurs, Marco W. J. ;
Oomen-de Hoop, Esther ;
van der Veldt, Astrid A. M. ;
Bins, Sander ;
Joosse, Arjen ;
Koolen, Stijn L. W. ;
Debets, Reno ;
Peeters, Robin P. ;
Aerts, Joachim G. J., V ;
Mathijssen, Ron H. J. ;
Medici, Marco .
THYROID, 2020, 30 (07) :966-973
[7]  
Beck-Peccoz P., 2022, PITUITARY, P615, DOI [10.1016/B978-0-323-99899-4.00012-3, DOI 10.1016/B978-0-323-99899-4.00012-3]
[8]   A descriptive, retrospective case series of patients with factitious disorder imposed on self [J].
Berar, Antoine ;
Bouzille, Guillaume ;
Jego, Patrick ;
Allain, Jean-Sebastien .
BMC PSYCHIATRY, 2021, 21 (01)
[9]   Thyroid hormone misuse and abuse [J].
Bernet, Victor J. .
ENDOCRINE, 2019, 66 (01) :79-86
[10]   The Relationship Between Iodine Intake and Serum Thyroglobulin in the General Population [J].
Bilek, R. ;
Cerovska, J. ;
Zamrazil, V. .
PHYSIOLOGICAL RESEARCH, 2015, 64 (03) :345-353